Varenicline Tartrate

Category API

Details	Specifications
CAS Number	375815-87-5
Molecular Formula	C17H19N3O6
Molecular Weight	361.35 g/mol.
Synonyms	7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-Dihydroxysuccinic Acid.
Chemical Name	7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-Dihydroxysuccinic Acid.
Common name	Varenicline tartarate
Therapeutic use	Varenicline is a smoking cessation aid. It works by mimicking the effect of nicotine by binding to the nicotine receptors in the brain
Background	Varenicline is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine receptor.
Grade	In house
Polymorph	Form-A
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	USDMF# 35037, ASMF # EU / ASMF / 00489
Manufacturing batch size	0.95 kg
Production capacity	Annual capacity 100 - 120 kg
Stability data	Available

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Varenicline Tartrate are also Available for

Questions & Answers

FAQ on Varenicline Tartrate

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.